Pediatrix Medical Group, Inc.
NYSE:MDMedical - Care Facilities
-$0.48 today
- Market cap
- $2.41B
- Beta
- 0.70
- P/E (TTM)
- 11.0
- EPS (TTM)
- $2.10
Volume 0.64M
Average 0.82M
MD Total Equity
Shareholders' claim on the company's assets after all liabilities: total assets minus total liabilities.
Pediatrix Medical Group, Inc.NYSE: MD
Total Equity · Q3 FY2026 · quarter ended Sep 2026
Total equity falls 4.6% from a year ago
Total equity stood at $849.62M at the end of Q3 FY2026, down 4.6% from a year earlier and down 3.6% from the prior quarter. Over 3 fiscal years it compounded at -1.0% a year.
Context
- Total equity amounted to 39.7% of total assets at the end of Q3 FY2026, down 0.8 pp from a year earlier.
- Total equity increased in 1 of the last 3 fiscal years.
What to watch
Whether total equity keeps falling in the next quarterly balance sheet after a -4.6% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Equity history
USD · from the balance sheet
- Latest · FY2025
- 865.85M USD
- Year-over-year change
- +13.2%
- 4-year CAGR
- -0.9%
| Period | Period end | Total Equity | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 865.85M | +13.2% |
| FY2024 | 2024-12-31 | 764.94M | -9.9% |
| FY2023 | 2023-12-31 | 849.06M | -4.8% |
| FY2022 | 2022-12-31 | 891.63M | -0.6% |
| FY2021 | 2021-12-31 | 896.69M | — |
Total Equity vs competitors
How MD compares with its peers on the latest reported figures
- MD's Sep 2026 total equity of $849.62M is the 8th highest of the 11 companies compared; the peer median is $1.17B.
- Its year-over-year change of -4.6% is the 10th highest of 11, against a peer median of +11.1%.
- Total equity amounts to 39.7% of total assets for MD, versus a peer median of 37.7%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $2.25B | -31.5% | -9.6% | 40.5% | |
| Mar 2026 | $2.11B | +2.9% | +13.5% | 34.9% | |
ARDTArdent Health Partners, LLC | Mar 2026 | $1.73B | +10.7% | +17.1% | 33.0% |
| Jun 2026 | $1.48B | +0.2% | +0.1% | 67.7% | |
| Sep 2026 | $1.19B | +31.7% | — | 8.9% | |
| Jun 2026 | $1.15B | +12.4% | +19.7% | 78.8% | |
| Sep 2026 | $1.13B | +6.9% | +7.0% | 54.7% | |
| Sep 2026 | $849.62M | -4.6% | -1.0% | 39.7% | |
| Mar 2026 | $577.46M | +11.5% | -0.0% | 24.5% | |
| Oct 2026 | $338.15M | +3310.8% | — | 15.3% | |
GRDNGuardian Pharmacy Services, Inc. | Jun 2026 | $257.64M | +43.4% | +42.1% | 58.1% |
| Peer median (excluding MD) | $1.17B | +11.1% | +10.3% | 37.7% | |
Competitors are the stored peer set for MD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 387.39M | 9.82M | 73.26M | 229.94M | 375.24M |
| Short-term Investments | 99.72M | 93.24M | 104.49M | 118.57M | 124.48M |
| Net Receivables | 316.02M | 296.79M | 279.88M | 272.6M | 242.31M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 18.9M | 13.26M | 12.31M | 5.09M | 8.88M |
| Total Current Assets | 840.56M | 427.99M | 483.45M | 639.61M | 763.51M |
| Property, Plant & Equipment (Net) | 135.62M | 140.21M | 145.93M | 78.44M | 73.51M |
| Goodwill | 1.51B | 1.53B | 1.38B | 1.24B | 1.26B |
| Intangible Assets | 21.57M | 18.49M | 21.24M | 11.6M | 16.86M |
| Long-term Investments | 0 | 0 | 0 | 0 | 20.8M |
| Tax Assets | 88.34M | 105.93M | 102.85M | 103.86M | 73.92M |
| Other Non-current Assets | 131.03M | 123.18M | 82.17M | 76.6M | 37.36M |
| Total Non-current Assets | 1.88B | 1.92B | 1.74B | 1.51B | 1.48B |
| Total Assets | 2.72B | 2.35B | 2.22B | 2.15B | 2.25B |
| Account Payables | 36.65M | 31.86M | 34.59M | 46.43M | 37.22M |
| Short-term Debt | 0 | 12.5M | 12.5M | 18.75M | 38.4M |
| Tax Payables | 46.07M | 51.25M | 38.7M | 37.62M | 984K |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 94.63M |
| Total Current Liabilities | 427.37M | 426.98M | 388.95M | 434.11M | 458.91M |
| Long-term Debt | 1B | 627.65M | 611.59M | 593.57M | 594.64M |
| Deferred Tax Liabilities | 41.41M | 33.64M | 34.31M | 34.25M | 57.02M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 313.43M | 315.04M | 281.84M | 290.34M | 243M |
| Total Non-current Liabilities | 1.4B | 1.03B | 981.8M | 953.65M | 921.93M |
| Total Liabilities | 1.83B | 1.46B | 1.37B | 1.39B | 1.38B |
| Common Stock | 864K | 829K | 840K | 859K | 830K |
| Retained Earnings | (155.39M) | (89.06M) | (149.47M) | (248.54M) | (83.15M) |
| Accumulated OCI | 1.32M | (3.74M) | (2.21M) | (1.07M) | 610K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 205K | 0 | 0 | 0 | 0 |
| Total Equity | 896.69M | 891.63M | 849.06M | 764.94M | 865.85M |
| Total Debt | 1.07B | 717.08M | 701.65M | 662.31M | 660.3M |
| Net Debt | 678.44M | 707.26M | 628.39M | 432.37M | 285.06M |
Pediatrix Medical Group, Inc.
NYSE:MD
Intrinsic Alpha fair value
Locked
Current Price
$30.84
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.